What are Value Stocks?
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.
Benzinga Insights has compiled a list of value stocks in the healthcare sector that may be worth watching:
- Palisade Bio PALI - P/E: 0.14
- Acumen Pharmaceuticals ABOS - P/E: 3.12
- Vir Biotechnology VIR - P/E: 6.18
- Athersys ATHX - P/E: 0.9
- Spok Holdings SPOK - P/E: 8.78
Palisade Bio has reported Q3 earnings per share at $-4.0, which has increased by 33.33% compared to Q2, which was -6.0. Acumen Pharmaceuticals saw a decrease in earnings per share from -0.25 in Q2 to $-0.26 now. Most recently, Vir Biotechnology reported earnings per share at $-0.76, whereas in Q3 earnings per share sat at $1.3. Athersys saw an increase in earnings per share from -2.25 in Q2 to $-1.15 now. Most recently, Spok Holdings reported earnings per share at $0.12, whereas in Q3 earnings per share sat at $0.15. Its most recent dividend yield is at 13.94%, which has decreased by 1.57% from 15.51% in the previous quarter.
The Significance: A value stock may need some time to rebound from its undervalued position. The risk of investing in a value stock is that this emergence may never materialize.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.